Dependence or withdrawal symptoms can occur with misuse
He completed his internship in Internal Medicine at Mount Sinai Medical Center and went on to complete his dermatology residency through Western University/Pacific Hospital, where he was selected as Chief Resident in the Department of Dermatology
Research on its long-term safety remains insufficient
In placebo-controlled adjunctive epilepsy trials in adults receiving topiramate 200 to 1,000 mg/day, hot flashes (1% to 2%), drug-induced body odor (0% to 1%), skin disorder (1% to 2%), hyperhidrosis (1% or less), and erythematous rash (1% or less) were reported with equal or greater frequency than placebo
GHK-Cu peptides also improve hydration levels by supporting natural moisturizing factors, enhancing moisture retention, and reinforcing the skin barrier